2020 EI Program

Please find the program below for the online EI presentations, 2020.



Effect of 6 months flash glucose monitoring in youth with type 1 diabetes and high-risk glycemic control – a randomized controlled trial
Dr Sara Boucher; Department of Women’s and Children’s Health, University of Otago, Dunedin, New Zealand


Gut Bugs Trial: a randomised double-blind placebo-controlled trial of faecal microbiome transfer for treatment of adolescent obesity and metabolic disorders
Dr Karen Leong;  Liggins Institute, University Of Auckland, Auckland, New Zealand


Impact of high-risk glycaemic control on habitual sleep quality and sleep patterns among youth (13-20 years) with type 1 diabetes mellitus compared to controls without diabetes.
Mrs Shelley Rose; Department of Women’s and Children’s Health, University Of Otago, Dunedin; Department of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand


For a high fat, high protein meal preprandial administration of 125% of the meal insulin dose improves postprandial glycaemia in people with Type 1 Diabetes using multiple daily injections.
Miss Tenele Smith;  John Hunter Children’s Hospital, New Lambton Heights, NSW; Hunter Medical Research Institute, New Lambton Heights, NSW; University of Newcastle, Callaghan, NSW Australia





A link will be sent to all APEG members the day prior to the session & AGM with a link to both Zoom meetings